Avidity Biosciences, Inc. (RNA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 10:56AM EDT. Market open.
| Previous close | 27.10 |
| Open | 26.40 |
| Bid | 19.08 x 200 |
| Ask | 32.93 x 200 |
| Day's range | 25.65 - 27.20 |
| 52-week range | 4.82 - 27.66 |
| Volume | |
| Avg. volume | 1,170,046 |
| Market cap | 2.472B |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Insider Sell: Avidity Biosciences Inc (RNA) President and CEO Sarah Boyce Sells 28,000 Shares
President and CEO Sarah Boyce of Avidity Biosciences Inc (NASDAQ:RNA) sold 28,000 shares of the company on April 2, 2024, according to a recent SEC filing.
- GuruFocus.com
Insider Sell: CFO Michael Maclean Sells 40,000 Shares of Avidity Biosciences Inc (RNA)
Michael Maclean, Chief Financial Officer of Avidity Biosciences Inc (NASDAQ:RNA), sold 40,000 shares of the company on March 13, 2024, according to a recent SEC filing.
- Investor's Business Daily
Top 2% Biotech Avidity Tumbles Despite 'Positive' Results In Treating Muscular Dystrophy
Top-notch biotech stock Avidity tumbled Monday despite unveiling "positive" midstage test results for its muscular dystrophy treatment.
© 2024 Yahoo. All rights reserved.